rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Quantum Cyber N.V. -

QUCY · Nasdaq

Health CareBiotechnologyNot moving yetAIAutonomyDefense-TechDefense-Tech

QUCY stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 18.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 2
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Insider trades held for review
2, left out of the totals
Officials’ trades on record
0
Institutions holding
16 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$2.0MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. 2 trades held for review are left out until their prices have been checked.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0
WhoDidSharesTraded
Kevin Michael Donahue10% ownerbought643,850price held for review17 Oct 2025filed 16 Jan 2026
Kevin Michael Donahue10% ownerbought685,000at $1.5117 Oct 2025filed 20 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+1 on the quarter
New · exited4 · 4
Reported value$281K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCadded · filed 14 Aug 202684,574$133K+68,481+425.5%
UBS Group AGreduced · filed 13 Aug 202626,110$41K-60,466−69.8%
Steward Partners Investment Advisory, LLCreduced · filed 13 Aug 202620,000$31K-10,000−33.3%
XTX Topco Ltdreduced · filed 14 Aug 202611,391$18K-52,876−82.3%
MORGAN STANLEYadded · filed 13 Aug 202611,187$18K+10,998+5819.0%
Journey Advisory Group, LLCreduced · filed 4 Aug 202610,000$16K-5,000−33.3%
Keystone Financial Group, Inc.new · filed 21 Jul 20265,300$8,321+5,300
Tower Research Capital LLC (TRC)new · filed 11 Aug 20264,000$6,280+4,000
OSAIC HOLDINGS, INC.new · filed 14 Aug 20262,190$3,438+2,190
SBI Securities Co., Ltd.reduced · filed 23 Jul 20261,289$2,024-10,349−88.9%
31 Dec 2024 – 30 Jun 2026
61217Dec 24Jun 25Sep 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

William J. Caragol Company insiderChief Financial Officer · last 11 Aug 20260 · 0
David E. Lazar Company insiderChief Executive Officer · last 5 Aug 20260 · 0
Avraham Ben-Tzvi Company insiderDirector · last 31 Jul 20260 · 0
David Natan Company insiderDirector · last 31 Jul 20260 · 0
Louis R. Buffalino Company insiderDirector · last 31 Jul 20260 · 0
Peter O'Rourke Company insiderDirector · last 31 Jul 20260 · 0
Gregory J. Tibbitts Company insiderDirector · last 13 Feb 20260 · 0
Guido Baechler Company insiderChief Executive Officer · last 13 Feb 20260 · 0
Heinrich Dreismann Company insiderDirector · last 13 Feb 20260 · 0
Kevin Michael Donahue Company insider10% owner · last 17 Oct 20252 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202572.6%
Debt to equityFY 2025 · to 31 Dec 20251.49×
Share count trendFY 2025 · to 30 Mar 202628.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$889K
Free cash flowFY 2025 · to 31 Dec 2025−$11.0M

Analyst forecasts

No analyst forecasts yet.